- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05615766
Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation (Exo4UL)
EXO4UL- Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation of Spinal Cord Injured Patients
Rehabilitation robotics has the potential to facilitate rehabilitation at home and empower people with spinal injuries to self-manage increasing their independence and improving their quality of life.
The objective of this study is to assess for the first time in the NHS the efficacy of a commercial robotic orthosis for upper limb rehabilitation in patients with spinal cord injury. The device is produced by Myomo (myomo.com) which is an American company. We will be assessing the wearable robotic orthosis also known as robotic exoskeleton in two different neuro-rehabilitation centres: National Spinal injuries Unit in Glasgow (Scotland) and The Robert Jones and Agnus Hunt Orthopaedic Hospital in Oswestry (England). The study will involve nine spinal cord injured tetraplegic inpatients in total.
Patients will follow a twelve-week rehabilitation programme with three to four sessions per week in addition to their usual care and rehabilitation. Each session lasts for approximately 45 minutes. Participants arm function, range of motion, spasticity level will be measured before, half-way and at the end of the programme to assess change in these and other parameters. Training will focus on the dominant arm of the patient and compared to the other arm at every assessment stage.
We shall evaluate therapists' and patients' satisfaction with the commercial device in addition to assessing various clinical measures to evaluate the efficacy of using the robotic orthosis in rehabilitation and recovery of arm function.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Heba Lakany, PhD
- Phone Number: +447737353181
- Email: heba.lakany@liverpool.ac.uk
Study Contact Backup
- Name: Karen Wilding
- Phone Number: +447717 863747
- Email: sponsor@liverpool.ac.uk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18+ years.
- The levels of C5 C6 Asia C/D would provide individuals with elbow and hand impairment and potentially functional shoulder movements. C7, C8 individuals could also benefit from the hand component of the device.
- Some gross shoulder movement at start of the trial to enable changes at the elbow/hand, to have the greatest potential for functional change.
- Preservation of hand sensation as base for motor restoration.
- Some sitting balance would give the best opportunity for the arm to be released for functional upper limb activity.
- EMG (muscle activity) evidence of active finger flexion, extension and elbow flexion extension Grade 1-2.
- Minimal or No community functional use of upper limb at start of trial.
- Spasticity MAS 1-3/5.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Device Intervention
The intervention group who will be undergoing rehabilitation using the robotic exoskeleton in addition to the assigned traditional rehabilitation programme on their dominant arm only.
|
The robotic rehabilitation programme using the MARK from Myomo (myomo.com)
for the intervention group will last for 12 weeks with up to four sessions of rehabilitation per week, i.e. total of 48 sessions.
Spinal cord injured inpatients in the study will have this intervention on their dominant arm in addition to the traditional rehabilitation programme assigned and standard care.
Other Names:
|
No Intervention: Control
the matched control group will be the same subjects undergoing traditional rehabilitation only on their non-dominant arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spinal Cord Independence Measure version III (SCIM III)
Time Frame: Change from baseline (week 1) at 6 weeks
|
assesses performance in activities of daily living and mobility for individuals with spinal cord injury
|
Change from baseline (week 1) at 6 weeks
|
Spinal Cord Independence Measure version III (SCIM III)
Time Frame: Change from baseline (week 1) at 12 weeks
|
assesses performance in activities of daily living and mobility for individuals with spinal cord injury
|
Change from baseline (week 1) at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP).
Time Frame: Change from baseline (week 1) at 6 weeks and 12 weeks
|
The GRASSP is a clinical impairment measure for the upper limb for use after tetraplegia.
The measure includes three domains which are important in describing hand function.
|
Change from baseline (week 1) at 6 weeks and 12 weeks
|
The modified Ashworth scale
Time Frame: Change from baseline (week 1) at 6 weeks and 12 weeks
|
Ashworth scale is the most universally accepted clinical spasticity assessment tool used to measure the increase of muscle tone.
|
Change from baseline (week 1) at 6 weeks and 12 weeks
|
Range of Motion
Time Frame: Change from baseline (week 1) at 6 weeks and 12 weeks
|
to assess the capability of a joint to go through its complete spectrum of movements
|
Change from baseline (week 1) at 6 weeks and 12 weeks
|
Canadian Occupational Performance Measure (COPM)
Time Frame: Change from baseline (week 1) at 6 weeks and 12 weeks
|
COPM assesses the patient's perceived occupational performance in the areas of selfcare, productivity, and leisure
|
Change from baseline (week 1) at 6 weeks and 12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0)
Time Frame: Change from baseline (week 1) at 6 weeks and 12 weeks
|
The QUEST 2.0 evaluates a patient's satisfaction with various assistive technologies.
|
Change from baseline (week 1) at 6 weeks and 12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Heba Lakany, PhD, University of Liverpool
- Study Director: Simon J Pickard, Robert Jones and Agnes Hunt Orthopaedic Hospital
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRAS312522
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
-
M.D. Anderson Cancer CenterActive, not recruitingMetastatic Epidural Spinal Cord CompressionUnited States
Clinical Trials on Experimental: Device Intervention
-
University of FloridaVillency Design Group, LLCCompletedBalanceUnited States
-
Assistance Publique - Hôpitaux de ParisMedtronic - MITG; Kimberly-Clark CorporationCompletedMechanical Ventilation Complication | Acute Respiratory FailureFrance
-
Vanderbilt UniversityAgency for Healthcare Research and Quality (AHRQ)Completed
-
Cynosure, Inc.Active, not recruitingAcne ScarsUnited States
-
LifeNet HealthWithdrawn
-
Philips Digital Mammography Sweden ABTerminatedBreast CancerUnited States
-
University of OklahomaRecruitingLymphoma | Breast CancerUnited States
-
Virginia Commonwealth UniversityMind and Life Institute, Hadley, MassachusettsRecruitingEmotion RegulationUnited States
-
Indiana UniversityWithdrawnTongue Cancer | Tongue TumorUnited States
-
Dominion Aesthetic Technologies, Inc.Completed